| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
1 company
Orbimed Israel Biofund GP Limited Partnership serves as a 10% Owner at PHGE. Across recent SEC filings that breaks down to 9 buys and 1 sell. Those positions are worth an estimated $5.3M at current prices.
Historically, Orbimed Israel Biofund GP Limited Partnership's trades have earned a below-average insider score of 33/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -10.5%.
The biggest single holding is PHGE (~$5.3M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 846,656 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 | PHGE Biomx Inc. | 10% Owner | Sell | 24,344 | $0.38 | $9,279.93 | -0.2% | -46.9% | -83.7% | |
| Feb 27, 2023 | PHGE Biomx Inc. | 10% Owner | Buy | 348,000 | $0.25 | $85,260.00 | +12.4% | -11.9% | -38.2% | |
| Jul 28, 2021 | PHGE Biomx Inc. | 10% Owner | Buy | 500,000 | $0.00 | - | +21.6% | -51.6% | -77.1% | |
| Dec 19, 2019 | PHGE Biomx Inc. | Director, 10% Owner | Buy | 4,000 | $8.90 | $35,615.00 | +0.2% | - | - | |
| Dec 11, 2019 | PHGE Biomx Inc. | Director, 10% Owner | Buy | 8,800 | $8.85 | $77,918.00 | +0.4% | - | - | |
| Dec 9, 2019 | PHGE Biomx Inc. | Director, 10% Owner | Buy | 10,200 | $8.40 | $85,646.00 | +0.4% | - | - |